Koyfin Home > Directory > Health Care > Gilead Sciences Inc > EBIT

Gilead Sciences Inc EBIT Chart (GILD)

Gilead Sciences Inc annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Gilead Sciences Inc EBIT for the quarter ending June 06, 2020 was $1,541m a 195.59% increase of 3,014m year over year
  • Gilead Sciences Inc EBIT for the last 12 months ending June 06, 2020 was $4,169m a -30.70% decrease of -1,280m year over year
  • Gilead Sciences Inc Annual EBIT for 2019 was $5,087m a -77.31% decrease of -3,933m from 2018
  • Gilead Sciences Inc Annual EBIT for 2018 was $9,020m a -56.59% decrease of -5,104m from 2017
  • Gilead Sciences Inc Annual EBIT for 2017 was $14,124m a -27.90% decrease of -3,941m from 2016
Other Income Statement Metrics:
  • Gilead Sciences Inc EBITDA for the quarter ending December 12, 2018 was $1,502m a -67.11% decrease of -1,008m year over year
  • Gilead Sciences Inc Net Income for the quarter ending December 12, 2018 was $3m a -51,166.67% decrease of -1,535m year over year
  • Gilead Sciences Inc Total Revenue for the quarter ending December 12, 2018 was $5,795m a 12.20% increase of 707m year over year
View Chart On Koyfin

Quarterly GILD EBIT Data

06/2020$1,541m
03/2020$2,402m
12/2019$1,893m
09/2019$-1,473m
06/2019$2,595m
03/2019$2,237m
12/2018$1,964m
09/2018$2,623m
06/2018$2,280m
03/2018$2,153m

Annual GILD EBIT Data

2019$5,087m
2018$9,020m
2017$14,124m
2016$18,065m
2015$22,193m
2014$15,265m
2013$4,524m
2012$4,299m
2011$3,818m
2010$3,962m